Digital Commons @ University of Digital Commons @ University of South Florida South Florida
暂无分享,去创建一个
[1] V. Uversky,et al. Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2 , 2020, Infection, Genetics and Evolution.
[2] Christopher J. Oldfield,et al. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses , 2020, Cellular and Molecular Life Sciences.
[3] Jonathan P. Davies,et al. Comparative multiplexed interactomics of SARS-CoV-2 and homologous coronavirus non-structural proteins identifies unique and shared host-cell dependencies , 2020, bioRxiv.
[4] L. Qiang,et al. Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications , 2020, SN Comprehensive Clinical Medicine.
[5] P. Hofman,et al. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists , 2020, Virchows Archiv.
[6] G. Fonarow,et al. COVID-19 Pandemic: Cardiovascular Complications and Future Implications , 2020, American Journal of Cardiovascular Drugs.
[7] A. Tong,et al. Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience , 2020, Frontiers in Neurology.
[8] F. Massari,et al. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer , 2020, Future oncology.
[9] S. Pascarella,et al. Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics? , 2020, BioMed research international.
[10] Paolo Fusar-Poli,et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic , 2020, The Lancet Psychiatry.
[11] Giuseppe Magro,et al. SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the ‘culprit lesion’ of ARDS onset? What is there besides Tocilizumab? SGP130Fc , 2020, Cytokine: X.
[12] F. Negro,et al. SARS-CoV-2 and liver damage: a possible pathogenetic link. , 2020, Hepatobiliary surgery and nutrition.
[13] Victor G. Puelles,et al. Multiorgan and Renal Tropism of SARS-CoV-2 , 2020, The New England journal of medicine.
[14] M. Rugge,et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532) , 2020, Annals of Oncology.
[15] L. Delgado-Roche,et al. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection , 2020, Archives of Medical Research.
[16] Tianyuan Wang,et al. Cytokine storm intervention in the early stages of COVID-19 pneumonia , 2020, Cytokine & Growth Factor Reviews.
[17] Chakrabarty Dibyajyoti Das Gopalakrishnan Bulusu Arijit Roy Broto. Network-Based Analysis of Fatal Comorbidities of COVID-19 and Potential Therapeutics , 2020 .
[18] V. Uversky,et al. Intrinsically disordered proteins of viruses: Involvement in the mechanism of cell regulation and pathogenesis , 2020, Progress in Molecular Biology and Translational Science.
[19] James A. Foster,et al. Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids , 2020, Microbial Pathogenesis.
[20] E. Bechara,et al. Structural analysis of SARS-CoV-2 and prediction of the human interactome , 2020, 2003.13655.
[21] V. Jha,et al. The Novel Coronavirus 2019 epidemic and kidneys , 2020, Kidney International.
[22] Arthur S Slutsky,et al. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target , 2020, Intensive Care Medicine.
[23] Lixia Chen,et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods , 2020, Acta Pharmaceutica Sinica B.
[24] Ujjwal Maulik,et al. Structural facets of POU2F1 in light of the functional annotations and sequence-structure patterns , 2020, Journal of biomolecular structure & dynamics.
[25] Ruchong Chen,et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China , 2020, The Lancet Oncology.
[26] E. Holmes,et al. A new coronavirus associated with human respiratory disease in China , 2020, Nature.
[27] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[28] A Keith Dunker,et al. Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity , 2020, Biomolecules.
[29] V. Uversky,et al. Evolutionary Analyses of Sequence and Structure Space Unravel the Structural Facets of SOD1 , 2019, Biomolecules.
[30] Vladimir N. Uversky,et al. Intrinsically Disordered Proteins and Their “Mysterious” (Meta)Physics , 2019, Front. Phys..
[31] U. Maulik,et al. Understanding the evolutionary trend of intrinsically structural disorders in cancer relevant proteins as probed by Shannon entropy scoring and structure network analysis , 2019, BMC Bioinformatics.
[32] L. Itzhaki,et al. Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2 , 2019, Scientific Reports.
[33] Johnson Wahengbam Luwang,et al. Phosphomimetic Mutation Destabilizes the Central Core Domain of Human p53 , 2018, IUBMB life.
[34] Zsuzsanna Dosztányi,et al. IUPred2A: context-dependent prediction of protein disorder as a function of redox state and protein binding , 2018, Nucleic Acids Res..
[35] Zhongming Zhao,et al. Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition , 2017, Nature Communications.
[36] Yongqi Huang,et al. Deciphering the promiscuous interactions between intrinsically disordered transactivation domains and the KIX domain , 2017, Proteins.
[37] K. Teilum,et al. Behaviour of intrinsically disordered proteins in protein–protein complexes with an emphasis on fuzziness , 2017, Cellular and Molecular Life Sciences.
[38] J. Clarke,et al. Conserved Helix-Flanking Prolines Modulate Intrinsically Disordered Protein:Target Affinity by Altering the Lifetime of the Bound Complex , 2017, Biochemistry.
[39] M. Hour,et al. SARS coronavirus papain-like protease up-regulates the collagen expression through non-Samd TGF-β1 signaling , 2017, Virus Research.
[40] Núria Queralt-Rosinach,et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..
[41] Lei Wan,et al. SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/p38 MAPK/STAT3 pathway , 2016, Scientific Reports.
[42] Lukasz Kurgan,et al. Disordered nucleiome: Abundance of intrinsic disorder in the DNA‐ and RNA‐binding proteins in 1121 species from Eukaryota, Bacteria and Archaea , 2016, Proteomics.
[43] A. Velázquez‐Campoy,et al. Structural and functional characterization of phosphomimetic mutants of cytochrome c at threonine 28 and serine 47. , 2016, Biochimica et biophysica acta.
[44] J. Forman-Kay,et al. Modulation of Intrinsically Disordered Protein Function by Post-translational Modifications , 2016, The Journal of Biological Chemistry.
[45] G. Lozano,et al. MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53. , 2016, Molecular cell.
[46] Fiona C. Denison,et al. Phosphomimetic mutation of a conserved serine residue in Arabidopsis thaliana 14-3-3ω suggests a regulatory role of phosphorylation in dimerization and target interactions. , 2015, Plant physiology and biochemistry : PPB.
[47] Lukasz Kurgan,et al. In various protein complexes, disordered protomers have large per‐residue surface areas and area of protein‐, DNA‐ and RNA‐binding interfaces , 2015, FEBS letters.
[48] K. Rajagopalan,et al. Phosphorylation-induced Conformational Ensemble Switching in an Intrinsically Disordered Cancer/Testis Antigen* , 2015, The Journal of Biological Chemistry.
[49] Yang Zhang,et al. The I-TASSER Suite: protein structure and function prediction , 2014, Nature Methods.
[50] L. Kay,et al. Folding of an intrinsically disordered protein by phosphorylation as a regulatory switch , 2014, Nature.
[51] C. Dieterich,et al. Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells. , 2014, Nature chemical biology.
[52] P. Nelson,et al. The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. , 2014, Cancer discovery.
[53] D. Meek,et al. Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters , 2014, Nucleic acids research.
[54] A Keith Dunker,et al. Intrinsically disordered proteins and intrinsically disordered protein regions. , 2014, Annual review of biochemistry.
[55] S. K. Maurya,et al. Caerulomycin A Enhances Transforming Growth Factor-β (TGF-β)-Smad3 Protein Signaling by Suppressing Interferon-γ (IFN-γ)-Signal Transducer and Activator of Transcription 1 (STAT1) Protein Signaling to Expand Regulatory T Cells (Tregs)* , 2014, The Journal of Biological Chemistry.
[56] Christopher J. Oldfield,et al. Classification of Intrinsically Disordered Regions and Proteins , 2014, Chemical reviews.
[57] Alexander Dömling,et al. Transient protein states in designing inhibitors of the MDM2-p53 interaction. , 2013, Structure.
[58] P. Pitha,et al. p53 Tumor Suppressor Protein Stability and Transcriptional Activity Are Targeted by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interferon Regulatory Factor 3 , 2013, Molecular and Cellular Biology.
[59] François-Xavier Theillet,et al. Site-specific NMR mapping and time-resolved monitoring of serine and threonine phosphorylation in reconstituted kinase reactions and mammalian cell extracts , 2013, Nature Protocols.
[60] S. Knapp,et al. Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP. , 2013, Cancer cell.
[61] V. Uversky. A decade and a half of protein intrinsic disorder: Biology still waits for physics , 2013, Protein science : a publication of the Protein Society.
[62] N. Ribeiro,et al. Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential , 2013, Chemistry & Biology.
[63] A. Dunker,et al. Understanding Viral Transmission Behavior via Protein Intrinsic Disorder Prediction: Coronaviruses , 2012, Journal of pathogens.
[64] W. Kamitani,et al. Severe Acute Respiratory Syndrome Coronavirus nsp1 Facilitates Efficient Propagation in Cells through a Specific Translational Shutoff of Host mRNA , 2012, Journal of Virology.
[65] Vladimir N Uversky,et al. Intrinsically disordered proteins and novel strategies for drug discovery , 2012, Expert opinion on drug discovery.
[66] Y. Zou,et al. DNA-PK, ATM and ATR collaboratively regulate p53-RPA interaction to facilitate homologous recombination DNA repair , 2012, Oncogene.
[67] I. Bahar,et al. Sequence Evolution Correlates with Structural Dynamics , 2012, Molecular biology and evolution.
[68] Carlo Camilloni,et al. Determination of secondary structure populations in disordered states of proteins using nuclear magnetic resonance chemical shifts. , 2012, Biochemistry.
[69] V. Uversky,et al. SS-Stabilizing Proteins Rationally: Intrinsic Disorder-Based Design of Stabilizing Disulphide Bridges in GFP , 2012, Journal of biomolecular structure & dynamics.
[70] Do-Hyoung Kim,et al. Understanding pre-structured motifs (PreSMos) in intrinsically unfolded proteins. , 2012, Current protein & peptide science.
[71] V. Uversky,et al. Molecular mechanisms of the anomalous thermal aggregation of green fluorescent protein. , 2011, Biochimica et biophysica acta.
[72] C. Sander,et al. Direct-coupling analysis of residue coevolution captures native contacts across many protein families , 2011, Proceedings of the National Academy of Sciences.
[73] Jiandong Chen,et al. Regulation of MDM2 E3 Ligase Activity by Phosphorylation after DNA Damage , 2011, Molecular and Cellular Biology.
[74] V. Uversky,et al. Sequential melting of two hydrophobic clusters within the green fluorescent protein GFP-cycle3. , 2011, Biochemistry.
[75] Peter E. Wright,et al. Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation , 2010, Proceedings of the National Academy of Sciences.
[76] B. Vojtesek,et al. A Novel p53 Phosphorylation Site within the MDM2 Ubiquitination Signal , 2010, The Journal of Biological Chemistry.
[77] M. Hüttemann,et al. Phosphomimetic substitution of cytochrome C tyrosine 48 decreases respiration and binding to cardiolipin and abolishes ability to trigger downstream caspase activation. , 2010, Biochemistry.
[78] Roland L. Dunbrack,et al. PONDR-FIT: a meta-predictor of intrinsically disordered amino acids. , 2010, Biochimica et biophysica acta.
[79] Chandra Verma,et al. Differences in the transactivation domains of p53 family members: a computational study , 2010, BMC Genomics.
[80] William Arbuthnot Sir Lane,et al. ATM activates p53 by regulating MDM2 oligomerization and E3 processivity , 2009, The EMBO journal.
[81] V. Uversky,et al. Solution structure and dynamics of the chimeric SH3 domains, SHH- and SHA-"Bergeracs". , 2009, Biochimica et biophysica acta.
[82] A Keith Dunker,et al. Analysis of structured and intrinsically disordered regions of transmembrane proteins. , 2009, Molecular bioSystems.
[83] T. Kamura,et al. Degradation of Phosphorylated p53 by Viral Protein-ECS E3 Ligase Complex , 2009, PLoS pathogens.
[84] Wei Gu,et al. Modes of p53 Regulation , 2009, Cell.
[85] H. Jane Dyson,et al. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2 , 2009, Proceedings of the National Academy of Sciences.
[86] H. Dyson,et al. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP. , 2009, Biochemistry.
[87] A. Fersht,et al. Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2 , 2009, Oncogene.
[88] A. Wlodawer,et al. Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. , 2009, Structure.
[89] V. Uversky,et al. Function and structure of inherently disordered proteins. , 2008, Current opinion in structural biology.
[90] T. Shono,et al. Phosphorylation of Thr18 and Ser20 of p53 in Ad-p53-induced apoptosis. , 2008, Neuro-oncology.
[91] A Keith Dunker,et al. A computational investigation of allostery in the catabolite activator protein. , 2007, Journal of the American Chemical Society.
[92] A. Fersht,et al. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53 , 2007, Proceedings of the National Academy of Sciences.
[93] S. Francoz,et al. Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[94] Geng-Hung Liu,et al. Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[95] S. Vishveshwara,et al. A network representation of protein structures: implications for protein stability. , 2005, Biophysical journal.
[96] P. Tompa,et al. IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content , 2005, Bioinform..
[97] K. Harms,et al. Structural basis for gene activation by p53 family members , 2005, Cancer biology & therapy.
[98] Zoran Obradovic,et al. Optimizing Long Intrinsic Disorder Predictors with Protein Evolutionary Information , 2005, J. Bioinform. Comput. Biol..
[99] Ana Sevilla,et al. p53 Stabilization and Accumulation Induced by Human Vaccinia-Related Kinase 1 , 2004, Molecular and Cellular Biology.
[100] E. Appella,et al. Phosphorylation Site Interdependence of Human p53 Post-translational Modifications in Response to Stress* , 2003, Journal of Biological Chemistry.
[101] M. McCoy,et al. Flexible lid to the p53-binding domain of human Mdm2: Implications for p53 regulation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[102] A. Haas,et al. MdmX Is a RING Finger Ubiquitin Ligase Capable of Synergistically Enhancing Mdm2 Ubiquitination* , 2002, The Journal of Biological Chemistry.
[103] A. Fersht,et al. Molecular mechanism of the interaction between MDM2 and p53. , 2002, Journal of molecular biology.
[104] C. Prives,et al. Efficient Specific DNA Binding by p53 Requires both Its Central and C-Terminal Domains as Revealed by Studies with High-Mobility Group 1 Protein , 2002, Molecular and Cellular Biology.
[105] M E J Newman,et al. Community structure in social and biological networks , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[106] N. Little,et al. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms , 2001, EMBO reports.
[107] V. Rotter,et al. Integrity of the N‐terminal transcription domain of p53 is required for mutant p53 interference with drug‐induced apoptosis , 2001, The EMBO journal.
[108] P. Chène. Targeting p53 in cancer. , 2001, Current medicinal chemistry. Anti-cancer agents.
[109] T. Hupp,et al. Inhibition of p53‐dependent transcription by BOX‐I phospho‐peptide mimetics that bind to p300 , 2001, EMBO reports.
[110] V. Rotter,et al. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. , 2000, Cancer research.
[111] Yusuke Nakamura,et al. p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53 , 2000, Cell.
[112] J. Stock,et al. Signal transduction: Response regulators on and off , 2000, Current Biology.
[113] K. Sakaguchi,et al. Damage-mediated Phosphorylation of Human p53 Threonine 18 through a Cascade Mediated by a Casein 1-like Kinase , 2000, The Journal of Biological Chemistry.
[114] D. Meek,et al. Protein kinase CK1 is a p53‐threonine 18 kinase which requires prior phosphorylation of serine 15 , 1999, FEBS letters.
[115] M. Oren. Regulation of the p53 Tumor Suppressor Protein* , 1999, The Journal of Biological Chemistry.
[116] C S Raman,et al. Isothermal titration calorimetry of protein-protein interactions. , 1999, Methods.
[117] S. Vishveshwara,et al. Identification of side-chain clusters in protein structures by a graph spectral method. , 1999, Journal of molecular biology.
[118] Yolande F M Ramos,et al. Comparative study of the p53-mdm2 and p53-MDMX interfaces , 1999, Oncogene.
[119] D. Livingston,et al. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. , 1998, Molecular cell.
[120] Ettore Appella,et al. Phosphorylation of p53: a Novel Pathway for p53 Inactivation in Human T-Cell Lymphotropic Virus Type 1-Transformed Cells , 1998, Journal of Virology.
[121] L. Johnson,et al. Structural basis for control by phosphorylation. , 1997, Chemical reviews.
[122] Yoichi Taya,et al. DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.
[123] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[124] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[125] A. Levine,et al. Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.
[126] A. Jochemsen,et al. MDMX: a novel p53‐binding protein with some functional properties of MDM2. , 1996, The EMBO journal.
[127] Bruce A. Johnson,et al. NMR View: A computer program for the visualization and analysis of NMR data , 1994, Journal of biomolecular NMR.
[128] D. Lane,et al. What the papers say: The p53‐mdm2 autoregulatory feedback loop: A paradigm for the regulation of growth control by p53? , 1993 .
[129] P. Meltzer,et al. Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.
[130] L. Donehower,et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.
[131] R. Doolittle,et al. A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.
[132] G. Daughdrill,et al. Using NMR Chemical Shifts to Determine Residue-Specific Secondary Structure Populations for Intrinsically Disordered Proteins. , 2018, Methods in enzymology.
[133] K. Rajarathnam,et al. Isothermal titration calorimetry of membrane proteins - progress and challenges. , 2014, Biochimica et biophysica acta.
[134] Sonia Longhi,et al. Structural disorder in viral proteins. , 2010, Protein and peptide letters.
[135] E. Lewis,et al. Isothermal titration calorimetry: experimental design, data analysis, and probing macromolecule/ligand binding and kinetic interactions. , 2008, Methods in cell biology.
[136] C. Chuong,et al. Article type Software , 2007 .
[137] Bruce A Johnson,et al. Using NMRView to visualize and analyze the NMR spectra of macromolecules. , 2004, Methods in molecular biology.
[138] Wei Zhang,et al. Mdm-2 binding and TAFII31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21 , 2002, Oncogene.
[139] V. Mikhail,et al. MINI REVIEW P53: AN UBIQUITOUS TARGET OF ANTICANCER DRUGS , 2002 .
[140] A Keith Dunker,et al. Intrinsic disorder and protein function. , 2002, Biochemistry.
[141] H. Dyson,et al. Insights into the structure and dynamics of unfolded proteins from nuclear magnetic resonance. , 2002, Advances in protein chemistry.
[142] P. Romero,et al. Sequence complexity of disordered protein , 2001, Proteins.
[143] M. Hollstein,et al. p53 and human cancer: the first ten thousand mutations. , 2000, Advances in cancer research.
[144] Wim G. J. Hol,et al. The role of the α-helix dipole in protein function and structure , 1985 .
[145] P. Radivojac,et al. PROTEINS: Structure, Function, and Bioinformatics Suppl 7:176–182 (2005) Exploiting Heterogeneous Sequence Properties Improves Prediction of Protein Disorder , 2022 .
[146] R. Sheridan,et al. a-Helix dipole model and electrostatic stabilization of 4-a-helical proteins , 2022 .